Altered TGFβ signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by fibulin-4 deficiency

[1]  Madhusudhan Budatha,et al.  Fibulin-4 Deficiency Results in Ascending Aortic Aneurysms: A Potential Link Between Abnormal Smooth Muscle Cell Phenotype and Aneurysm Progression , 2010, Circulation research.

[2]  Peter Nürnberg,et al.  Mutations in PYCR1 cause cutis laxa with progeroid features , 2009, Nature Genetics.

[3]  J. Hoyer,et al.  Lethal cutis laxa with contractural arachnodactyly, overgrowth and soft tissue bleeding due to a novel homozygous fibulin‐4 gene mutation , 2009, Clinical genetics.

[4]  M. Dubé,et al.  Mutation in pyrroline-5-carboxylate reductase 1 gene in families with cutis laxa type 2. , 2009, American journal of human genetics.

[5]  Ron A Wevers,et al.  Autosomal recessive cutis laxa syndrome revisited , 2009, European Journal of Human Genetics.

[6]  Takako Sasaki,et al.  Latent Transforming Growth Factor β-binding Proteins and Fibulins Compete for Fibrillin-1 and Exhibit Exquisite Specificities in Binding Sites* , 2009, The Journal of Biological Chemistry.

[7]  A. Mégarbané,et al.  A p.C217R mutation in fibulin-5 from cutis laxa patients is associated with incomplete extracellular matrix formation in a skin equivalent model. , 2008, The Journal of investigative dermatology.

[8]  M. Parker,et al.  De Barsy syndrome: a review of the phenotype , 2008, Clinical dysmorphology.

[9]  S. Nik-Zainal,et al.  Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families , 2008, Human mutation.

[10]  Takako Sasaki,et al.  Compound heterozygous mutations in fibulin‐4 causing neonatal lethal pulmonary artery occlusion, aortic aneurysm, arachnodactyly, and mild cutis laxa , 2007, American journal of medical genetics. Part A.

[11]  R. Timpl,et al.  A Comparative Analysis of the Fibulin Protein Family , 2007, Journal of Biological Chemistry.

[12]  H. Dietz,et al.  Perturbations of Vascular Homeostasis and Aortic Valve Abnormalities in Fibulin-4 Deficient Mice , 2007, Circulation research.

[13]  P. Byers,et al.  Aneurysm syndromes caused by mutations in the TGF-beta receptor. , 2006, The New England journal of medicine.

[14]  George H. Thomas,et al.  Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor , 2006 .

[15]  Reza Kalhor,et al.  Homozygous missense mutation in fibulin-5 in an Iranian autosomal recessive cutis laxa pedigree and associated haplotype. , 2006, The Journal of investigative dermatology.

[16]  Katherine H Kim,et al.  Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome. , 2006, American journal of human genetics.

[17]  Marc K. Halushka,et al.  Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.

[18]  H. Dietz,et al.  Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome , 2006, Nature Genetics.

[19]  R. Mecham,et al.  Targeted Disruption of Fibulin-4 Abolishes Elastogenesis and Causes Perinatal Lethality in Mice , 2006, Molecular and Cellular Biology.

[20]  J. Reymond,et al.  Inflammatory destruction of elastic fibers in acquired cutis laxa is associated with missense alleles in the elastin and fibulin-5 genes. , 2006, The Journal of investigative dermatology.

[21]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[22]  M. Crepeau,et al.  Aortic aneurysmal disease and cutis laxa caused by defects in the elastin gene , 2005, Journal of Medical Genetics.

[23]  A. Shuttleworth,et al.  Fibulin-5 interacts with fibrillin-1 molecules and microfibrils. , 2005, The Biochemical journal.

[24]  O. Başpınar,et al.  Long tortuous aorta in a child with Larsen syndrome. , 2005, The Canadian journal of cardiology.

[25]  D. Judge,et al.  TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome , 2004 .

[26]  S. Puig,et al.  A novel elastin gene mutation resulting in an autosomal dominant form of cutis laxa. , 2004, Archives of dermatology.

[27]  L. Greene,et al.  Fibulins: physiological and disease perspectives , 2003, EMBO reports.

[28]  R. Timpl,et al.  Genetic heterogeneity of cutis laxa: a heterozygous tandem duplication within the fibulin-5 (FBLN5) gene. , 2003, American journal of human genetics.

[29]  D. Arking,et al.  Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome , 2003, Nature Genetics.

[30]  Paul Coucke,et al.  Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. , 2002, Human molecular genetics.

[31]  Masashi Yanagisawa,et al.  Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo , 2002, Nature.

[32]  Tasuku Honjo,et al.  Fibulin-5/DANCE is essential for elastogenesis in vivo , 2002, Nature.

[33]  R. Timpl,et al.  Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4. , 1999, Matrix biology : journal of the International Society for Matrix Biology.

[34]  R. Timpl,et al.  Tropoelastin binding to fibulins, nidogen‐2 and other extracellular matrix proteins , 1999, FEBS letters.

[35]  J M Davidson,et al.  Cutis Laxa Arising from Frameshift Mutations in Exon 30 of the Elastin Gene (ELN)* , 1999, The Journal of Biological Chemistry.

[36]  M. Tassabehji,et al.  An elastin gene mutation producing abnormal tropoelastin and abnormal elastic fibres in a patient with autosomal dominant cutis laxa. , 1998, Human molecular genetics.

[37]  E. Haan,et al.  Clinicopathologic findings in congenital aneurysms of the great vessels. , 1996, American journal of medical genetics.

[38]  P. Handford,et al.  The structure of a Ca2+-binding epidermal growth factor-like domain: Its role in protein-protein interactions , 1995, Cell.

[39]  Gert Matthijs,et al.  Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2 , 2008, Nature Genetics.

[40]  D. Judge,et al.  TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. , 2004, The Journal of clinical investigation.

[41]  D. Arking,et al.  Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. , 2003, Nature genetics.

[42]  D. Stuart,et al.  The structure of a Ca(2+)-binding epidermal growth factor-like domain: its role in protein-protein interactions. , 1995, Cell.